CalciMedica (CALC) Depreciation & Amortization (CF) (2019 - 2026)
CalciMedica's (CALC) quarterly Depreciation & Amortization (CF) came in at $7000.0 in Q1 2026, down 53.33% YoY from $15000.0 in Q1 2025, and up 40.0% on a QoQ basis from $5000.0 in Q4 2025.
CalciMedica (CALC) Depreciation & Amortization (CF) (2019 - 2026) Analysis & Trends
CalciMedica (CALC) has 8 years of Depreciation & Amortization (CF) data on file, last reported at $7000.0 in Q1 2026.
- Quarterly Depreciation & Amortization (CF) fell 53.33% year-over-year to $7000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $37000.0 (down 36.21% YoY) and the FY2025 annual result came in at $46000.0, down 20.69% from the prior year.
- Depreciation & Amortization (CF) climbed to $7000.0 in Q1 2026, from $5000.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $19000.0 in Q4 2023 to a low of $5000.0 in Q4 2025.
- A 5-year average of $12941.2 and a median of $13000.0 in 2022 frame the typical range for Depreciation & Amortization (CF).
- Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) plunged 90.44% — and 2023, when it surged 46.15%.
- Tracing CALC's Depreciation & Amortization (CF) over 5 years: stood at $13000.0 in 2022, then jumped by 46.15% to $19000.0 in 2023, then declined by 26.32% to $14000.0 in 2024, then sank by 64.29% to $5000.0 in 2025, then jumped by 40.0% to $7000.0 in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $7000.0 (Q1 2026), $5000.0 (Q4 2025), and $11000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 56.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 123.70 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 40.52 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 191.83 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | CalciMedica | 9.80 Mn | -8.82 Mn | - | 7,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7,000.00 |
| Jun 30, 2026 | 7,000.00 |
| Mar 31, 2026 | 7,000.00 |
| Mar 31, 2026 | 7,000.00 |
| Dec 31, 2025 | 5,000.00 |
| Dec 31, 2025 | 5,000.00 |
| Sep 30, 2025 | 11,000.00 |
| Sep 30, 2025 | 11,000.00 |
| Jun 30, 2025 | 14,000.00 |
| Jun 30, 2025 | 14,000.00 |
| Mar 31, 2025 | 15,000.00 |
| Mar 31, 2025 | 15,000.00 |
| Dec 31, 2024 | 14,000.00 |
| Dec 31, 2024 | 14,000.00 |
| Sep 30, 2024 | 14,000.00 |
| Sep 30, 2024 | 14,000.00 |
| Jun 30, 2024 | 15,000.00 |
| Jun 30, 2024 | 15,000.00 |
| Mar 31, 2024 | 15,000.00 |
| Mar 31, 2024 | 15,000.00 |